Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer

doi:10.3748/wjg.v23.i28.5187

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8298)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

496

WORD

286

HTML

3316

Figures (1-2)

281

Tables (1-4)

227

Sum=4606

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1068

Download

2624

Sum=3692

Jul 28, 2017 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jul 28, 2017; 23(28): 5187-5195
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves of venous thromboembolism-free survival of the whole cohort of gastrointestinal cancer patients. Comparison between patients stratified on HOMA index (Panel A; HR = 3.17, 95%CI: 1.61-6.23) or fasting blood glucose (Panel B; HR = 4.21, 95%CI: 2.09-8.46).

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves of venous thromboembolism-free survival of non-diabetic non-obese gastrointestinal cancer patients. Comparison between patients stratified on HOMA index (Panel A; HR = 2.67, 95%CI: 1.05-6.80) or fasting blood glucose (Panel B; HR = 3.38, 95%CI: 1.19-9.57).

Citation: Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D’Alessandro R, Della-Morte D, Ferroni P, Roselli M. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol 2017; 23(28): 5187-5195
URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5187.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5187